The efficacy and safety of intraductal radiofrequency ablation in the treatment of benign bile duct tumor

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0006630

Enrollment

Registered

2021-10-01

Start date

2021-10-04

Completion date

Unknown

Last updated

2021-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device, Procedure/Surgery : Place a RFA catheter suitable for the degree and length of the stenosis in the stricture area according to the guide wire guidance. RFA is performed on the strictur

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) 20 years of age or older 2) Patients with benign bile duct tumor confirmed by biopsy 3) Patients with benign bile duct tumors who cannot or refuse surgical resection due to poor general condition 4) A person who has signed the written consent of the subject to participate in this study

Exclusion criteria

Exclusion criteria: 1) Patients with recurrent bile duct tumor after radical surgery 2) Patients with malignant bile duct tumor 3) If you have other active or uncontrolled diseases 4) In case of liver dysfunction due to diseases other than benign biliary tumor 5) Patients whose general condition is so poor that treatment cannot be performed or cannot cooperate 6) Patients who refuse to participate in this study

Design outcomes

Primary

Measure	Time frame
The clinical success rate of endoscopic intraductal radiofrequency ablation	—

Secondary

Measure	Time frame
Early complication of endoscopic intraductal radiofrequency ablation	—

Countries

Korea, Republic of

Contacts

Public ContactSung Yong Han

Pusan National University Hospital

mirsaint@hanmail.net+82-51-240-7869

Outcome results